Imunon Inc (IMNN)
0.9799
+0.03
(+3.15%)
USD |
NASDAQ |
Nov 04, 16:00
0.98
0.00 (0.00%)
After-Hours: 06:29
Imunon Total Liabilities (Quarterly): 5.950M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 5.950M |
March 31, 2024 | 5.825M |
December 31, 2023 | 8.530M |
September 30, 2023 | 6.583M |
June 30, 2023 | 7.207M |
March 31, 2023 | 15.46M |
December 31, 2022 | 14.65M |
September 30, 2022 | 19.18M |
June 30, 2022 | 18.29M |
March 31, 2022 | 18.08M |
December 31, 2021 | 18.25M |
September 30, 2021 | 20.13M |
June 30, 2021 | 18.96M |
March 31, 2021 | 18.08M |
December 31, 2020 | 18.92M |
September 30, 2020 | 18.62M |
June 30, 2020 | 22.51M |
March 31, 2020 | 22.73M |
December 31, 2019 | 23.72M |
September 30, 2019 | 25.10M |
June 30, 2019 | 24.76M |
March 31, 2019 | 24.00M |
December 31, 2018 | 25.99M |
September 30, 2018 | 25.78M |
June 30, 2018 | 30.36M |
Date | Value |
---|---|
March 31, 2018 | 20.39M |
December 31, 2017 | 20.81M |
September 30, 2017 | 20.71M |
June 30, 2017 | 23.01M |
March 31, 2017 | 24.69M |
December 31, 2016 | 24.12M |
September 30, 2016 | 26.89M |
June 30, 2016 | 27.00M |
March 31, 2016 | 28.02M |
December 31, 2015 | 28.64M |
September 30, 2015 | 28.58M |
June 30, 2015 | 31.31M |
March 31, 2015 | 33.08M |
December 31, 2014 | 33.87M |
September 30, 2014 | 34.66M |
June 30, 2014 | 34.22M |
March 31, 2014 | 14.15M |
December 31, 2013 | 14.15M |
September 30, 2013 | 18.29M |
June 30, 2013 | 18.02M |
March 31, 2013 | 15.66M |
December 31, 2012 | 13.40M |
September 30, 2012 | 12.39M |
June 30, 2012 | 11.96M |
March 31, 2012 | 6.675M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.825M
Minimum
Mar 2024
23.72M
Maximum
Dec 2019
15.88M
Average
18.25M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
Merck & Co Inc | 68.98B |
Cormedix Inc | 18.87M |
Brainstorm Cell Therapeutics Inc | 9.21M |
Predictive Oncology Inc | 6.493M |
Outlook Therapeutics Inc | 130.77M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 9.692M |
Shareholders Equity (Quarterly) | 3.741M |